LU79271A1 - Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons - Google Patents

Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons

Info

Publication number
LU79271A1
LU79271A1 LU79271A LU79271A LU79271A1 LU 79271 A1 LU79271 A1 LU 79271A1 LU 79271 A LU79271 A LU 79271A LU 79271 A LU79271 A LU 79271A LU 79271 A1 LU79271 A1 LU 79271A1
Authority
LU
Luxembourg
Prior art keywords
fluorprednisolone
preparation
new derivatives
derivatives
new
Prior art date
Application number
LU79271A
Other languages
English (en)
Inventor
R Wiechert
H Laurent
J Kapp
H Wendt
H Hofmeister
K Annen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2712862A external-priority patent/DE2712862C2/de
Priority claimed from DE19782809732 external-priority patent/DE2809732C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of LU79271A1 publication Critical patent/LU79271A1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU79271A 1977-03-21 1978-03-20 Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons LU79271A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2712862A DE2712862C2 (de) 1977-03-21 1977-03-21 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19782809732 DE2809732C2 (de) 1978-03-03 1978-03-03 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate, die diese Wirkstoffe enthalten

Publications (1)

Publication Number Publication Date
LU79271A1 true LU79271A1 (de) 1978-06-29

Family

ID=25771793

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79271A LU79271A1 (de) 1977-03-21 1978-03-20 Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons

Country Status (20)

Country Link
JP (1) JPS53130651A (de)
AT (1) AT365203B (de)
AU (1) AU525614B2 (de)
CA (1) CA1104124A (de)
CH (1) CH638226A5 (de)
CS (1) CS202591B2 (de)
DD (1) DD134955A5 (de)
DK (1) DK126378A (de)
ES (1) ES468107A1 (de)
FR (1) FR2384792A1 (de)
GB (1) GB1603281A (de)
GR (1) GR70385B (de)
IE (1) IE46584B1 (de)
IL (1) IL54308A (de)
IT (1) IT1095477B (de)
LU (1) LU79271A1 (de)
NO (1) NO151043C (de)
NZ (1) NZ186735A (de)
RO (1) RO81525B (de)
SE (1) SE431656B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
JPH07213320A (ja) * 1994-02-04 1995-08-15 Daiwa:Kk 長尺物用バック

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride
CH529739A (fr) * 1972-02-28 1972-10-31 Sdc Steroidi Dev Co Procédé pour la préparation d'un stéroïde de la série des prégnadiènes
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids

Also Published As

Publication number Publication date
NO780984L (no) 1978-09-22
RO81525A (ro) 1983-04-29
DD134955A5 (de) 1979-04-04
AU525614B2 (en) 1982-11-18
JPS6131116B2 (de) 1986-07-17
IE780545L (en) 1978-09-21
RO81525B (ro) 1983-04-30
IT1095477B (it) 1985-08-10
AT365203B (de) 1981-12-28
JPS53130651A (en) 1978-11-14
NO151043B (no) 1984-10-22
CS202591B2 (en) 1981-01-30
FR2384792B1 (de) 1980-04-04
AU3434678A (en) 1979-09-27
IT7821364A0 (it) 1978-03-20
DK126378A (da) 1978-09-22
IE46584B1 (en) 1983-07-27
ES468107A1 (es) 1979-07-01
SE7803168L (sv) 1978-09-22
GR70385B (de) 1982-10-05
IL54308A0 (en) 1978-06-15
IL54308A (en) 1984-03-30
CH638226A5 (en) 1983-09-15
FR2384792A1 (fr) 1978-10-20
NO151043C (no) 1985-01-30
SE431656B (sv) 1984-02-20
ATA195978A (de) 1981-05-15
GB1603281A (en) 1981-11-25
NZ186735A (en) 1980-10-24
CA1104124A (en) 1981-06-30

Similar Documents

Publication Publication Date Title
DD130788A5 (de) Verfahren zur herstellung von neuen alkyloximderivaten der 7-amino-thiazolylazetamidozephalosporansaeure
DD132663A5 (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
ATA162876A (de) Verfahren zur herstellung von neuen piperazinyliminorifamycinen
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD134088A5 (de) Verfahren zur herstellung von neuen pyrrolidinderivaten
AT350748B (de) Verfahren zur herstellung von neuen d-17alpha- aethinyl-17beta-acyloxy-19-nortestosteron-3- oximen
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
ATA292078A (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
DD135283A5 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
LU80001A1 (de) Verfahren zur herstellung von neuen imidazo-isochinolindionen
AT358577B (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
AT353286B (de) Verfahren zur herstellung von neuen 9- -hydroxyaethoxymethylguaninderivaten
PT68989A (de) Verfahren zur herstellung von neuen arylaminoimidazolinderivaten
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
DD130240A5 (de) Verfahren zur herstellung von acylcyaniden
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD134100A5 (de) Verfahren zur herstellung von lactamen
LU79271A1 (de) Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
AT352697B (de) Verfahren zur herstellung von neuen cyclohexen- (1)-dion-(3,6)-tetraalkyldiketalen
LU78135A1 (de) Verfahren zur herstellung von benzodifuranen